HELEN ANDERSON: Open Payments
NPI 1619391364 · DEMOTTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,025 in 168 payments from 38 companies in 2025. Trend: 2023 $14 · 2024 $410 · 2025 $5,025
Food & beverage: $5,025
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 11 | $676 |
| JAZZ PHARMACEUTICALS INC. | 13 | $411 |
| Novartis Pharmaceuticals Corporation | 11 | $400 |
| ARGENX US, INC. | 8 | $298 |
| LivaNova USA, Inc. | 2 | $276 |
| Avadel CNS Pharmaceuticals, LLC | 11 | $276 |
| TG Therapeutics, Inc. | 8 | $251 |
| Axsome Therapeutics, Inc. | 11 | $230 |
| Teva Pharmaceuticals USA, Inc. | 7 | $194 |
| ACADIA Pharmaceuticals Inc | 6 | $179 |
Products named: KESIMPTA, VUMERITY, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, LUMRYZ, BRIUMVI, TYSABRI, EPIDIOLEX, VYVGART.
Industry payments across IN — which companies pay providers there.
